about
Observational research, randomised trials, and two views of medical scienceCombined oral contraceptives: venous thrombosisCombined oral contraceptives: venous thrombosisDifferent combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysisFNH-like nodules: Possible precursor lesions in patients with focal nodular hyperplasia (FNH)Association of adenoma and focal nodular hyperplasia: experience of a single French academic centerCauses of venous thrombosisNovel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathwayActivation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia StudyThird generation oral contraceptives and risk of venous thrombosis: meta-analysisSynergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosisVaricose vein trauma: a risk for pulmonary embolism.Drug-induced hematologic syndromesLiving near major traffic roads and risk of deep vein thrombosis.Deep vein thrombosis: a clinical review.Thrombin generation profiles in deep venous thrombosis.The phenomenon known as acquired activated protein C resistance.Diane-35 (cyproterone acetate): safety concernsDrospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review.Evidence-based approach to thrombophilia testing.Oral contraceptives and venous thromboembolism: which are the safest preparations available?Tentative guidelines and practical suggestions to avoid venous thromboembolism during oral contraceptive therapy.Exposure to particulate air pollution and risk of deep vein thrombosis.Laboratory thrombophilias and venous thromboembolism.Delay in diagnosis of cerebral venous and sinus thrombosis: successful use of mechanical thrombectomy and thrombolysis.Hormonal birth control and pregnancy: a comparative analysis of thromboembolic risk.Hypercoagulable state testing and malignancy screening following venous thromboembolic events.Sinus sigmoideus thrombosis secondary to graves' disease: a case descriptionThrombophilia and stroke.Postpartum mood disorders: a review of clinical and epidemiological factors.Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study.Contraception in Canada: a review of method choices, characteristics, adherence and approaches to counselling.Hyperhomocysteinemia and other thrombophilic risk factors in 26 patients with cerebral venous thrombosis.Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pillIliac vein compression syndrome in an active and healthy young femaleDeep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin.Hormones and pregnancy: thromboembolic risks for women.Bilateral Spontaneous Perirenal Hemorrhage due to Initial Presentation of Polyarteritis Nodosa.New insights into the mechanisms of venous thrombosis.Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models.
P2860
Q21144655-A8CC8FDC-15C1-4022-A2F2-C252E0FBD740Q24198113-D166D684-22F1-400F-94CE-74217DE64F9AQ24202769-DF8BFD34-5C67-4186-AC55-3ABB8CFA07A8Q24624180-08DA3AEE-080F-4D84-90A4-F4750BE905A4Q24791036-8EE907B5-5D55-4796-A3DC-7F7FAD2BB900Q24802860-4027AD70-4028-42AA-A1B8-2FA05288DCD5Q28080150-78BDCBD6-A0B9-4A7B-86E3-C454E99938A8Q28083349-A3DE61D0-C1BD-4B9F-A470-122A53CE40F0Q28168368-CF436382-38DF-4041-85BD-8F4D97AA5E28Q28344562-EEEC2879-D906-4472-8F52-FE6060515CC8Q28754730-72B0269D-2F5C-4643-9AFB-EFE779610D45Q33165033-6DC1FD66-8DFA-4BEB-A7A3-95FA0F227C05Q33387312-0CCD0B2C-0841-4D71-A45B-0B86DFACD29CQ33955783-C40A5343-617D-443A-A1B6-645E7DBF32D8Q34144439-F29B37A5-5640-4418-98B7-F58550EB1A08Q34469944-B2BB526C-A384-4E25-A333-7CDCCAE34292Q34530144-72D04B4C-A07A-40E6-95B3-645CEED52CAEQ34536900-2E11401B-574C-4A87-B93E-AF42CB548ACCQ34636421-471800EE-613C-451B-8BD6-008ABDC601EBQ34663749-810281A3-9D5C-4BAE-80D3-C766C380E94DQ34743953-EB5DA663-C782-4807-9FD5-F894408D0D1CQ34743964-F5589899-E045-4BB9-9FCE-71EF88743598Q34979338-AA4E6A34-2609-4090-8B91-52A890616D80Q34981644-5004CC5E-DE0B-4B80-BC74-A244C20B2C00Q35110384-BEA382C1-92F6-4330-B5FE-483CB45C5ECEQ35139270-E369CA25-34F2-4A2C-A34C-9AABE3FB82C6Q35179215-B60BA9D7-79F7-4E54-B390-369656136CE7Q35545645-D6FE9BDF-8E1E-44E1-BD5F-EEB4458672F3Q35610110-3B5B8C62-752D-451C-A1B5-09C2FF03C967Q35619341-858F408A-879D-4661-9370-E1F637231988Q35664040-AC9F0C92-DBE1-4D73-9CE3-8D6150F7DAD6Q35688513-2208CFAE-D6F9-4ECE-9431-C69562BFA78EQ35788910-D7935A20-5E4A-48D5-86AE-D6D29FBF0FF4Q35803802-AE7A802A-BADD-4EA5-97EA-FE14B4E75EC7Q35808433-55BAE062-7667-48FE-8FC1-938523C0C80EQ35827099-13A92FA7-A269-4A2E-BDFD-C0F24426462FQ35852845-DB243A4E-BB32-41EF-A6ED-A6B59AEE367AQ36059548-790E6139-9188-40A5-8A44-4F40F6449F0BQ36068279-1A12D6A8-4801-49C0-B4B8-ADA74C1E6D68Q36172482-FDCB81A1-AE3B-4916-B57B-0AC7F8BD5568
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Oral contraceptives and the risk of venous thrombosis.
@ast
Oral contraceptives and the risk of venous thrombosis.
@en
Oral contraceptives and the risk of venous thrombosis.
@nl
type
label
Oral contraceptives and the risk of venous thrombosis.
@ast
Oral contraceptives and the risk of venous thrombosis.
@en
Oral contraceptives and the risk of venous thrombosis.
@nl
prefLabel
Oral contraceptives and the risk of venous thrombosis.
@ast
Oral contraceptives and the risk of venous thrombosis.
@en
Oral contraceptives and the risk of venous thrombosis.
@nl
P2093
P1476
Oral contraceptives and the risk of venous thrombosis.
@en
P2093
Bloemenkamp KW
Helmerhorst FM
Middeldorp S
Rosendaal FR
Vandenbroucke JP
P304
P356
10.1056/NEJM200105173442007
P407
P577
2001-05-01T00:00:00Z